Cargando…

A novel angiotensin II peptide vaccine without an adjuvant in mice

We recently developed a novel peptide, AJP001, that possesses both a mouse T-cell epitope and adjuvant action. Direct conjugation to the antigen is useful for peptide vaccines without the addition of adjuvants. In this study, the efficacy of an angiotensin (Ang) II and AJP001-conjugated peptide vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamaru, Ryo, Nakagami, Hironori, Hayashi, Hiroki, Sun, Jiao, Tenma, Akiko, Yamamoto, Koichi, Shimamura, Munehisa, Morishita, Ryuichi, Rakugi, Hiromi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	ORIGINAL PAPERS: Therapeutic aspects
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752219/ https://www.ncbi.nlm.nih.gov/pubmed/32667158 http://dx.doi.org/10.1097/HJH.0000000000002597

Ejemplares similares

AJP001, a novel helper T‐cell epitope, induces a humoral immune response with activation of innate immunity when included in a peptide vaccine
por: Tenma, Akiko, et al.
Publicado: (2019)

Therapeutic vaccine for chronic diseases after the COVID-19 Era
por: Nakagami, Hironori, et al.
Publicado: (2021)

The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice
por: Yoshida, Shota, et al.
Publicado: (2020)

Prevention of bleomycin-induced pulmonary fibrosis by a RANKL peptide in mice
por: Ju, Nan, et al.
Publicado: (2022)

Preventative effects of the partial RANKL peptide MHP1-AcN in a mouse model of imiquimod-induced psoriasis
por: Ju, Nan, et al.
Publicado: (2019)

Peptide-based vaccine targeting IL17A attenuates experimental spondyloarthritis in HLA-B27 transgenic rats
por: Hayashi, Hiroki, et al.
Publicado: (2023)

Decrease in Blood Pressure and Regression of Cardiovascular Complications by Angiotensin II Vaccine in Mice
por: Nakagami, Futoshi, et al.
Publicado: (2013)

Development of an IL-17A DNA Vaccine to Treat Systemic Lupus Erythematosus in Mice
por: Koriyama, Hiroshi, et al.
Publicado: (2020)

A Novel Therapeutic Peptide as a Partial Agonist of RANKL in Ischemic Stroke
por: Kurinami, Hitomi, et al.
Publicado: (2016)

Development of anti-thrombotic vaccine against human S100A9 in rhesus monkey
por: Shimamura, Munehisa, et al.
Publicado: (2021)

Gene Therapy and Cell-Based Therapies for Therapeutic Angiogenesis in Peripheral Artery Disease
por: Shimamura, Munehisa, et al.
Publicado: (2013)

A peptide vaccine targeting angiotensin II attenuates the cardiac dysfunction induced by myocardial infarction
por: Watanabe, Ryo, et al.
Publicado: (2017)

Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice
por: Kawakami, Ryo, et al.
Publicado: (2018)

Therapeutic Effects of Systemic Administration of the Novel RANKL-Modified Peptide, MHP1, for Ischemic Stroke in Mice
por: Shimamura, Munehisa, et al.
Publicado: (2018)

Preclinical study of a DNA vaccine targeting SARS-CoV-2
por: Hayashi, Hiroki, et al.
Publicado: (2022)

Development of a novel RANKL-based peptide, microglial healing peptide1-AcN (MHP1-AcN), for treatment of ischemic stroke
por: Shimamura, Munehisa, et al.
Publicado: (2018)

Phase I Study to Assess the Safety and Immunogenicity of an Intradermal COVID-19 DNA Vaccine Administered Using a Pyro-Drive Jet Injector in Healthy Adults
por: Nakagami, Hironori, et al.
Publicado: (2022)

Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis
por: Rakugi, Hiromi, et al.
Publicado: (2015)

Novel Anti-Microbial Peptide SR-0379 Accelerates Wound Healing via the PI3 Kinase/Akt/mTOR Pathway
por: Tomioka, Hideki, et al.
Publicado: (2014)

Possible modification of Alzheimer’s disease by statins in midlife: interactions with genetic and non-genetic risk factors
por: Shinohara, Mitsuru, et al.
Publicado: (2014)

Intradermal administration of DNA vaccine targeting Omicron SARS-CoV-2 via pyro-drive jet injector provides the prolonged neutralizing antibody production via germinal center reaction
por: Hayashi, Hiroki, et al.
Publicado: (2023)

Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variant
por: Hayashi, Hiroki, et al.
Publicado: (2022)

A novel chronic dural port platform for continuous collection of cerebrospinal fluid and intrathecal drug delivery in free-moving mice
por: Nakajima, Tsuneo, et al.
Publicado: (2022)

Inhibition of Neointima Formation through DNA Vaccination for Apolipoprotein(a): A New Therapeutic Strategy for Lipoprotein(a)
por: Kyutoku, Mariko, et al.
Publicado: (2013)

Peptide Vaccines for Hypertension and Diabetes Mellitus
por: Nakagami, Hironori, et al.
Publicado: (2014)

Novel Method for Rapid Assessment of Cognitive Impairment Using High-Performance Eye-Tracking Technology
por: Oyama, Akane, et al.
Publicado: (2019)

ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19
por: Yamamoto, Koichi, et al.
Publicado: (2020)

Cardiac and Renal Protective Effects of Irbesartan via Peroxisome Proliferator‐Activated Receptorγ–Hepatocyte Growth Factor Pathway Independent of Angiotensin II Type 1a Receptor Blockade in Mouse Model of Salt‐Sensitive Hypertension
por: Kusunoki, Hiroshi, et al.
Publicado: (2013)

Insight into the Role of Angiopoietins in Ageing-Associated Diseases
por: Hayashi, Shin-ichiro, et al.
Publicado: (2020)

Laryngeal Edema That Developed after Acute Myocardial Infarction
por: Nakagami, Futoshi, et al.
Publicado: (2019)

Development of novel DNA vaccine for VEGF in murine cancer model
por: Kyutoku, Mariko, et al.
Publicado: (2013)

Recent Progress in Therapeutic Angiogenesis
por: Nakagami, Hironori, et al.
Publicado: (2007)

Low alpha-synuclein levels in the blood are associated with insulin resistance
por: Rodriguez-Araujo, Gerardo, et al.
Publicado: (2015)

Temporal and spatial profile of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) in ischemic stroke in mice
por: Kawano, Tomohiro, et al.
Publicado: (2019)

Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial
por: Mancia, Giuseppe, et al.
Publicado: (2014)

Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy
por: Schumacher, Christoph D., et al.
Publicado: (2013)

More rigorous protocol adherence to intensive structured management improves blood pressure control in primary care: results from the Valsartan Intensified Primary carE Reduction of Blood Pressure study
por: Stewart, Simon, et al.
Publicado: (2014)

Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012
por: Sengul, Sule, et al.
Publicado: (2016)

Evaluation of renal nerve morphological changes and norepinephrine levels following treatment with novel bipolar radiofrequency delivery systems in a porcine model
por: Cohen-Mazor, Meital, et al.
Publicado: (2014)

Time of administration important? Morning versus evening dosing of valsartan
por: Zappe, Dion H., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v195oevudc84fchk9jbaqgb9tt